Search

Your search keyword '"Townsend, Alain R"' showing total 207 results

Search Constraints

Start Over You searched for: Author "Townsend, Alain R" Remove constraint Author: "Townsend, Alain R"
207 results on '"Townsend, Alain R"'

Search Results

1. Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses

2. Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells

3. Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells

6. The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine

7. Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells

8. Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells

9. A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses

10. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

11. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

14. Structure–function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans

15. Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology

16. Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

17. Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology

19. Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

21. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models

22. Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models

23. Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models

24. Lung-targeting lentiviral vector for passive immunisation against influenza

25. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

26. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

27. Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

29. Correction: Breadth and function of antibody response to acute SARS-CoV-2 infection in humans

30. Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern

34. Correction: Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans

35. Hepcidin-mediated hypoferremia disrupts immune\ud responses to vaccination and infection

36. The antigenic anatomy of SARS-CoV-2 receptor binding domain

37. Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans

38. Breadth and function of antibody response to acute SARS-CoV-2 infection in humans

39. Natural and vaccine-induced antibody and cellular responses against emerging SARS-CoV-2 variants of concern

40. Recognition of Z-RNA by ADAR1 limits interferon responses

42. Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus

43. A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses

44. Breadth and function of antibody response to acute SARS-CoV-2 infection in humans

45. Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans

48. Semaphorin 3A induces cytoskeletal paralysis in tumor-specific CD8+ T cells

50. Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

Catalog

Books, media, physical & digital resources